傳特斯拉年底前或將再次降價
在近期經歷過兩次促銷後,特斯拉(TSLA.US)的中國訂單增量仍不及預期。市場消息稱,該品牌有可能會在年底前進一步推出新的“降價手段”以促進銷量。
特斯拉在10月底宣佈 Model 3、Model Y降價,降幅達1.4萬-3.7萬元。在宣佈降價後,特斯拉中國的官網一度被蜂擁而至的流量擠到“癱瘓”。消息來源表示,促銷並沒有給特斯拉帶來預想的效果。這一輪特斯拉收穫的訂單僅有 5 萬個左右,“而非外界瘋傳的 10-17 萬個”。
根據招銀國際的一份報告顯示,10月特斯拉上海工廠的產量爲87706輛,高出交付量71704輛(中國市場交付+ 出口)約1.6萬輛。據瞭解,這是自特斯拉2019年年底開設上海工廠以來,產銷差距最大的一次。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.